X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
index medicus (19) 19
male (17) 17
prostate cancer (17) 17
oncology (13) 13
cell line, tumor (11) 11
androgen receptor (9) 9
animals (8) 8
hsp90 heat-shock proteins - antagonists & inhibitors (8) 8
cancer (7) 7
prostatic neoplasms - drug therapy (7) 7
prostatic neoplasms - pathology (7) 7
receptors, androgen - metabolism (7) 7
antineoplastic agents - pharmacology (6) 6
cell proliferation (6) 6
cell proliferation - drug effects (6) 6
endocrinology & metabolism (6) 6
prostatic neoplasms - metabolism (6) 6
signal transduction (6) 6
apoptosis (5) 5
clinical trials (5) 5
growth (5) 5
prostate (5) 5
receptors, androgen - genetics (5) 5
analysis (4) 4
apoptosis - drug effects (4) 4
benzoquinones - pharmacology (4) 4
castration (4) 4
explants (4) 4
expression (4) 4
heat-shock-protein (4) 4
hsp90 (4) 4
hsp90 heat-shock proteins - metabolism (4) 4
in-vitro (4) 4
inhibitors (4) 4
isoxazoles - pharmacology (4) 4
lactams, macrocyclic - pharmacology (4) 4
prostatic neoplasms, castration-resistant - metabolism (4) 4
research (4) 4
resorcinols - pharmacology (4) 4
17-allylamino-17-demethoxygeldanamycin (3) 3
androgens (3) 3
antineoplastic agents (3) 3
article (3) 3
breast-cancer (3) 3
cancer research (3) 3
carcinogenesis (3) 3
cell biology (3) 3
cell survival - drug effects (3) 3
ex vivo (3) 3
ex-vivo culture (3) 3
gene-expression (3) 3
genetics (3) 3
heat shock proteins (3) 3
ligand-binding domain (3) 3
mice (3) 3
models, molecular (3) 3
prostatic neoplasms - genetics (3) 3
prostatic neoplasms, castration-resistant - drug therapy (3) 3
protein structure, tertiary (3) 3
proteins (3) 3
receptors, androgen - chemistry (3) 3
transcription, genetic - drug effects (3) 3
tumor cells, cultured (3) 3
tumor microenvironment (3) 3
tumors (3) 3
urology & nephrology (3) 3
activation (2) 2
advanced solid tumors (2) 2
aged (2) 2
androgens - metabolism (2) 2
anilides - pharmacology (2) 2
antimitotic agents (2) 2
binding (2) 2
biomarkers, tumor - genetics (2) 2
breast neoplasms - metabolism (2) 2
breast neoplasms - pathology (2) 2
cancer cells (2) 2
carcinogens (2) 2
care and treatment (2) 2
cell lines (2) 2
cell survival (2) 2
clinical-trials (2) 2
development and progression (2) 2
dna (2) 2
dna-binding (2) 2
drug discovery (2) 2
drug resistance, neoplasm - drug effects (2) 2
epithelial cells (2) 2
estrogen receptor alpha - metabolism (2) 2
gene-mutations (2) 2
genetic variation (2) 2
glucocorticoid-receptor (2) 2
health aspects (2) 2
hsp90 heat-shock proteins - chemistry (2) 2
hsp90 inhibitor (2) 2
hsp90 protein (2) 2
immunohistochemistry (2) 2
medicine (2) 2
middle aged (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2011, Volume 6, Issue 9, pp. e25634 - e25634
DNA methylation plays an important role in carcinogenesis and the reversibility of this epigenetic modification makes it a potential therapeutic target. To... 
BREAST-CANCER | PROMOTER METHYLATION | HYPOMETHYLATING AGENT | ANTINEOPLASTIC ACTION | CPG ISLAND HYPERMETHYLATION | MOUSE MODEL | BIOLOGY | GENE-EXPRESSION | RISK MYELODYSPLASTIC SYNDROME | PHASE-I | L1210 LEUKEMIA | Azacitidine - adverse effects | Gene Silencing - drug effects | Biomarkers, Tumor - deficiency | Humans | Cytidine - pharmacology | Male | Cytidine - analogs & derivatives | Promoter Regions, Genetic - drug effects | Promoter Regions, Genetic - genetics | Dose-Response Relationship, Drug | Prostatic Neoplasms - genetics | Time Factors | Glutathione S-Transferase pi - deficiency | Prostatic Neoplasms - blood | Cell Death - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Glutathione S-Transferase pi - genetics | Enzyme Inhibitors - adverse effects | Cell Survival - drug effects | Prostatic Neoplasms - pathology | Enzyme Inhibitors - pharmacology | Azacitidine - analogs & derivatives | Drug Discovery | Prostate-Specific Antigen - blood | Azacitidine - pharmacology | Cell Line, Tumor | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | DNA Methylation - drug effects | Epigenetic inheritance | Cell death | DNA | Cancer cells | Genetic aspects | Research | Methylation | Drug therapy | Health aspects | Prostate cancer | Cancer | Cell proliferation | Medical research | Effectiveness | Mortality | Clinical trials | Gene expression | Carcinogenesis | Studies | Demethylation | Carcinogens | Androgens | Glutathione transferase | DNA methylation | DNA methyltransferase | Prostate | Deoxyribonucleic acid--DNA | Index Medicus | Deoxyribonucleic acid
Journal Article
BMC cancer, ISSN 1471-2407, 03/2016, Volume 16, Issue 1, pp. 177 - 177
Journal Article
Journal Article
Journal Article
The Prostate, ISSN 0270-4137, 03/2018, Volume 78, Issue 4, pp. 308 - 317
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2012, Volume 18, Issue 13, pp. 3562 - 3570
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 1152 - 1152
Journal Article
Oncotarget, ISSN 1949-2553, 05/2013, Volume 4, Issue 5, pp. 691 - 704
The development of lethal, castration resistant prostate cancer is associated with adaptive changes to the androgen receptor (AR), including the emergence of... 
Variant | HSP90 | HSP90 inhibitor | Prostate cancer | Androgen receptor | Index Medicus
Journal Article